Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Impedimed Limited (AU:IPD)
ASX:IPD
Impedimed Limited (IPD) Share Price & Analysis
6 Followers
IPD Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.08 - AU$0.24
Previous CloseAU$0.09
Volume97.43K
Average Volume (3M)3.67M
Market Cap
AU$178.04M
Enterprise ValueAU$141.52M
Total Cash (Recent Filing)AU$40.73M
Total Debt (Recent Filing)AU$170.00K
Price to Earnings (P/E)-8.8
Beta1.35
Next Earnings
Feb 26, 2024EPS Estimate
>-AU$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares OutstandingN/A
10 Day Avg. Volume8,638,887
30 Day Avg. Volume3,673,333
Standard Deviation0.25
R-Squared0.19
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$1.37Price Target Upside1455.14% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Impedimed Limited News
PremiumCompany Announcements
ImpediMed Announces Strategic Leadership Reshuffle
PremiumCompany Announcements
Impedimed Announces Over 10M Securities CessationOptions Prices
Currently, No data available
---
Ownership Overview
3.79% Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
96.20% Public Companies and
Individual Investors
IPD FAQ
What was Impedimed Limited’s price range in the past 12 months?
Impedimed Limited lowest share price was AU$0.08 and its highest was AU$0.24 in the past 12 months.
What is Impedimed Limited’s market cap?
Currently, no data Available
When is Impedimed Limited’s upcoming earnings report date?
Impedimed Limited’s upcoming earnings report date is Feb 26, 2024 which is 60 days ago.
How were Impedimed Limited’s earnings last quarter?
Impedimed Limited released its earnings results on Aug 30, 2023. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of AU$0 by -AU$0.005.
Is Impedimed Limited overvalued?
According to Wall Street analysts Impedimed Limited’s price is currently Undervalued.
Does Impedimed Limited pay dividends?
Impedimed Limited does not currently pay dividends.
What is Impedimed Limited’s EPS estimate?
Impedimed Limited’s EPS estimate is >-AU$0.01.
How many shares outstanding does Impedimed Limited have?
Impedimed Limited has 2,023,093,900 shares outstanding.
What happened to Impedimed Limited’s price movement after its last earnings report?
Impedimed Limited reported an EPS of -AU$0.005 in its last earnings report, missing expectations of AU$0. Following the earnings report the stock price went down -6.977%.
Which hedge fund is a major shareholder of Impedimed Limited?
Currently, no hedge funds are holding shares in AU:IPD
---
Impedimed Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$1.37 (1455.14% Upside)
AU$1.37 (1455.14% Upside)
Blogger Sentiment
Bullish
AU:IPD Sentiment 93%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $149.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.36%
12-Months-Change
Fundamentals
Return on Equity
-41.33%
Trailing 12-Months
Asset Growth
22.24%
Trailing 12-Months
Company Description
Impedimed Limited
ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. It operates through the Medical, and Test and Measurement segments. The Medical segment supplies non-invasive medical technology products and services to measure, monitor, and manage tissue composition and fluid status using bioimpedance spectroscopy. The Test and Measurement segment offers power precision testing and measuring equipment. The company was founded by Melvyn John Bridges and Lucille Mayse Bridges on September 27, 1999 and is headquartered in Pinkenba, Australia.
---
IPD Stock 12 Months Forecast
Average Price Target
AU$1.37
▲(1455.14% Upside)
Technical Analysis
Best Analysts Covering IPD
1 Year
1 Year Success Rate
6/10 ratings generated profit
1 Year Average Return
+17.59%
reiterated a buy rating 3 months ago
Copying Shane Storey's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +17.59% per trade.
---